2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
10
Breast Neoplasms
9
Ovarian Neoplasms
8
Prostatic Neoplasms
7
Multiple Myeloma
6
Lung Neoplasms
6
Hematologic Neoplasms
6
Depression
5
Sleep Initiation and Maintenance Disorders
4
Motor Activity
4
Fatigue
4
Breast Carcinoma In Situ
4
Anxiety Disorders
4
Leukemia
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Sleep Wake Disorders
2
Pancreatic Neoplasms
2
Pain
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
Interventions
Exercise
6
Transcranial Direct Current Stimulation
4
Neuropsychological Tests
4
Walking
3
Memantine
3
Tablets
2
Standard of Care
2
Patient Reported Outcome Measures
2
Methods
2
Electroencephalography
2
Drug Therapy
2
Donepezil
2
Cognitive Behavioral Therapy
2
mazdutide
1
lithium sulfate
1
lime
1
fasudil
1
enzalutamide
1
blueberry extract
1
beta Carotene
1
acetaminophen, aspirin, caffeine drug combination
1
XENP 1595
1
Vitamin E
1
Vitamin D
1
Ultraviolet Therapy
1
Transcranial Magnetic Stimulation
1
Time
1
Therapeutics
1
Tai Ji
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognitive Dysfunction
×
Behavior Therapy
×
Clear all
NCT03191968
2019-12-20
BOOST
University of Illinois at Urbana-Champaign
Phase 2
Completed
27 enrolled